Molecules that simultaneously inhibit lactylation and acetylation—such as p300/CBP bifunctional inhibitors (110), or combinations with DNA methylation/demethylation drugs such as azacitidine are being explored to enhance anti-tumor efficacy (111). This evidence concerns the gene EP300 and neoplasm.